1. Market Research
  2. > Biotechnology

When biology meets technology: must-read reports and analysis

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
11 votes

Global Biotechnology Industry


The global biotechnology industry is forecast to exceed $320 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by economic recovery, increased R&D funding, government initiatives and biotechnology used in agriculture and medical sciences. Developing nations, particularly China and India, are becoming major markets in the fields of agricultural and industrial biotechnology.


The economic crisis negatively impacted the biotechnology market, and brought about revenue declines in the US and the EU as a result of limited capital inflows and the delay or cancellation of projects. The market has entered a phase of recovery, with many large biotechnology outfits generating revenue thanks to new cost-savings and efficiency measures.


Industry funding is on the rise on the back of more favorable economic conditions, though this funding is concentrated in a small number of larger outfits. Smaller companies are still struggling to raise R&D funds. The situation is likely to improve as venture capitalists exercise greater caution in seeking more secure investment options.


Key Market Segments


Biological Therapy - The biotechnology industry was further segmented in 2011, steered away from its traditional drug focus and into other fields, including cleantech and chemical manufacturing. BCC Research points to the focus on funding in low-possibility-of-success (POS) areas, such as antineoplastic and immunomodulating agents over other fields with greater success potential such as dermatology or acute diseases.


Genetic Testing represents an important market if we consider diagnosis as the key to better quality healthcare. This segment involves testing for chromosome, protein and gene abnormality or changes linked with inherited medical conditions. The global genetic testing industry is in a period of strong growth, fuelled by rising numbers of genetic disorders, better awareness and an aging population. The market was worth $1.5 billion in 2010, reports RNCOS.


The world genetic testing (and genomics) market is expected to reach $4 billion by 2015. Genetic testing for cancer is likely to experience one of the highest growth rates, receiving particular interest from the private sector and the scientific community at large. Direct-to-consumer genetic testing is a market segment that is likely to take off, with many new outfits on the market. Market shapers include 23andme and deCODE.


Biopharmaceuticals - Global enzyme demand is expected to grow, with the market expected to exceed $7.5 billion in 2010, according to Freedonia. The majority of markets are forecast to record yearly growth in of more than 5%, except for biofuel production and certain other smaller industrial enzyme segments. Regional growth rates will be highest in markets like the Africa/Mideast region, and Central and South America. Growth will be comparatively lower in established economies such as the US and the EU. Enzyme demand in North America will be negatively impacted by a slow switch over to biomass-based biofuel production. EU enzyme demand will be negatively impacted by the EU debt crisis.



Regional Market Share


The US dominates the global biotechnology industry, followed by developed EU nations such as Germany, Spain, France and the UK, reports Global Industry Analysts. Developing nations like China and India are likely to record strong growth in agricultural and industrial biotechnology industries due to rising income levels and population. Both countries are playing an increasingly significant role in the biotech drugs market on the back of relatively low-cost investment and a high level of expertise.



Market Outlook


Growth in the global biotechnology industry will be driven by improving healthcare infrastructure and increasing private-sector interest in information technology, according to Global Industry Analysts. There will likely be increasing merger and acquisitions activity over the coming years, driven by blockbuster drug patent expiration and healthcare regulations put in place to control costs. Smaller outfits will likely divest their businesses to larger outfits, or lean on in-licensing collaborations and partnerships with more financially secure outfits due to capital limitations.


Technological advancements, increasingly strict regulatory policies, public awareness and intellectual property are among the factors that will positively affect the biotechnology sector. Biotechnology applications will continue to increase, with agricultural, environmental sciences, medical, health and food sectors major end-use domains.


Biotech investments will continue to be aimed at new drug and therapy discoveries, led by specializations such as oncology, inflammation and cardiology. Therapeutic categories, including hormone treatment and diabetes, will receive increased attention from biotech drug companies in response to rising treatment demand in these sectors.



Leading Industry Associations


Understand the Biotechnology Industry Quickly & Get Actionable Data Easily. The Latest Reports with Statistics & Trends from Top Industry Sources
1-10 of about 12 000 reports

Global Biotechnology Industry

  • September 2015
    26 pages
  • Biotechnology  

  • World  

View report >

Biotechnology Industry in the US

  • November 2015
    23 pages
  • United States  

    North America  

View report >

Animal Biotechnology Markets in Europe

  • February 2015
    13 pages
  • Animal Biotechn  


  • Europe  


View report >

Biotechnology Industry in India and Asia

  • July 2013
    110 pages
  • Biotechnology  


    Crop Production  

  • India  


View report >

Biotechnology Industry in France

  • January 2015
    69 pages
  • Protein  

    Synthetic Biolo  

  • France  

View report >

Biotechnology Industry in Italy

  • January 2014
    70 pages
  • Biotechnology  

  • Italy  

View report >

Biotechnology Industry in the UK Monthly Update

  • January 2015
    6 pages
  • United Kingdom  


View report >

Biotechnology Industry in Canada

  • October 2013
    48 pages
  • Canada  

View report >

Biotechnology Industry in Brazil Forecast

  • August 2014
    16 pages
  • Biotechnology  


  • Brazil  


View report >

The future of the Biotechnology Industry in Russia

  • January 2015
    10 pages
  • Biotechnology  

  • Russian Federat  


View report >

About 4 700 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 9 850)

2015 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

2015 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

  • $ 9 850
  • Industry report
  • September 2015
  • by Venture Planning Group

This report provides the following data: Geographic Coverage:-          France-          Germany-          Italy-          Japan-          Spain-          ...

2015 Global Survey On Liquid Biopsy Adoption Trends ...

November 2015 $ 8 000

Medical Affairs Reputations (eu5): Type 2 Diabetes Mell ...

October 2015 $ 6 900

Single-cell Genomics And Proteomics: Emerging Technolog ...

October 2015 $ 6 650

Composites In Automotive Applications

October 2015 $ 6 650

Cell Expansion Technologies And Global Markets

September 2015 $ 6 650

Nanotechnology In Medical Applications: The Global Mark ...

September 2015 $ 6 650

Advances In Monoclonal Antibody Therapeutics 

September 2015 $ 6 500

Transforming Cancer Treatment With Immunotherapy (techv ...

September 2015 $ 6 500

Advances In Gene Therapy (techvision) 

September 2015 $ 6 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.